SUMMIT THERAPEUTICS PLC's ticker is SMMT and the CUSIP is 86627R102. A total of 6 filers reported holding SUMMIT THERAPEUTICS PLC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,462 | -21.3% | 782 | +5.7% | 0.00% | – |
| Q2 2023 | $1,857 | -74.5% | 740 | -82.2% | 0.00% | -100.0% |
| Q1 2023 | $7,291 | +479.6% | 4,166 | +1307.4% | 0.00% | – |
| Q4 2022 | $1,258 | – | 296 | +100.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 148 | -43.7% | 0.00% | – |
| Q3 2021 | $1,000 | -80.0% | 263 | -61.3% | 0.00% | -100.0% |
| Q2 2021 | $5,000 | 0.0% | 680 | -22.5% | 0.00% | 0.0% |
| Q1 2021 | $5,000 | +25.0% | 877 | +4.0% | 0.00% | 0.0% |
| Q4 2020 | $4,000 | – | 843 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 212,018 | $2,349,000 | 0.28% |
| Granite Point Capital Management, L.P. | 242,113 | $2,683,000 | 0.26% |
| LANSDOWNE PARTNERS (UK) LLP | 1,596,666 | $17,691,000 | 0.16% |
| Point72 Asset Management, L.P. | 785,600 | $8,704,000 | 0.04% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 80,000 | $886,000 | 0.02% |
| AXA S.A. | 282,760 | $3,133,000 | 0.01% |
| Polar Capital LLP | 100,000 | $1,108,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 144,083 | $1,595,000 | 0.01% |
| First Eagle Investment Management, LLC | 194,900 | $2,159,000 | 0.01% |
| Alyeska Investment Group, L.P. | 50,000 | $554,000 | 0.00% |